Advertisement

Efficacy of urinary glucose for diabetes screening: a reconsideration

  • Juan Chen
  • Haijian Guo
  • Suixia Yuan
  • Chen Qu
  • Tao Mao
  • Shanhu Qiu
  • Wei Li
  • Xiaohang Wang
  • Min Cai
  • Hong Sun
  • Bei Wang
  • Xiaoning Li
  • Zilin Sun
Original Article

Abstract

Aims

Previous studies indicated that urinary glucose (UG) had a limited efficacy in diabetes screening. This study was designed to have a re-evaluation of its efficacy, taking into consideration the collection method of urine and the measurement approach for UG among Chinese adults.

Methods

This cross-sectional study enrolled a total of 7689 participants without known diabetes, who were fasted and asked to empty bladders before a 75 g glucose loading. Urine was collected 2 h post glucose loading, and UG was measured using quantitative and qualitative approaches. The efficacy of UG in detecting diabetes was assessed by the receiver operating characteristic (ROC) curve.

Results

The area under the ROC curve was 0.89 for quantitative UG and 0.87 for qualitative UG. Quantitative UG was positively correlated with fasting plasma glucose (FPG) and 2 h plasma glucose (2 h PG) (r = 0.55 and 0.56, respectively, both P < 0.001). Quantitative UG displayed a sensitivity of 82.9% and a specificity of 84.7% in detecting diabetes at the corresponding optimal cutoff of 130 mg. Qualitative UG exhibited a sensitivity of 80.2% and a specificity of 85.6% at the optimal cutoff of glycosuria + 1. In addition, the sensitivity of both quantitative and qualitative UG was significantly higher than that of HbA1c (≥ 6.5%) (P < 0.001) and had a comparable sensitivity to 2 h PG (≥ 11.1 mmol/L) (P = 0.493).

Conclusions

UG, either quantitatively or qualitatively measured at 2 h post glucose loading, was effective in diabetes screening. This indicates that UG is a feasible approach for diabetes screening.

Keywords

Diabetes mellitus Screening Glycosuria Urinary glucose 

Notes

Acknowledgements

We owe our sincere thanks to the local research teams and colleagues for assistance in participant recruitment. We are grateful to many residents of Jiangsu Province who participated in this study. We thank all the staff who were involved in this study for their important contributions.

Funding

This work was supported by a grant from the National Key R&D Program of China (2016YFC1305700), the National Key Scientific Instrument and Equipment Development Project of China (No. 51627808) and  the Key Program for Clinical Medicine and Science and Technology, Jiangsu Province, China (BL2014079).

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of Jiangsu Provincial Center for Disease Control and Prevention and Zhongda Hospital, Southeast University and with the 1964 Helsinki Declaration and its later amendments.

Informed consent

Informed consent was obtained from all participants included in the study.

Data availability

Data are available from the corresponding author for researchers who meet the criteria for access to confidential data. Please contact Zilin Sun (email: sunzilin1963@126.com).

References

  1. 1.
    Guariguata L, Whiting DR, Hambleton I et al (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149.  https://doi.org/10.1016/j.diabres.2013.11.002 CrossRefPubMedGoogle Scholar
  2. 2.
    Xu Y, Wang L, He J et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310:948–959.  https://doi.org/10.1001/jama.2013.168118 CrossRefPubMedGoogle Scholar
  3. 3.
    Laiteerapong N, Cifu AS (2016) Screening for prediabetes and type 2 diabetes mellitus. JAMA 315:697–698.  https://doi.org/10.1001/jama.2015.17545 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Yang W, Lu J, Weng J et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101.  https://doi.org/10.1056/NEJMoa0908292 CrossRefPubMedGoogle Scholar
  5. 5.
    Wild SH, Smith FB, Lee AJ, Fowkes FG (2005) Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort. Diabet Med 22:490–496.  https://doi.org/10.1111/j.1464-5491.2004.01433.x CrossRefPubMedGoogle Scholar
  6. 6.
    da RFJ, Ogurtsova, Linnenkamp K, Guariguata U et al (2016) IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117:48–54.  https://doi.org/10.1016/j.diabres.2016.04.016 CrossRefPubMedGoogle Scholar
  7. 7.
    Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV (2002) Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. Diabetes Care 25:1365–1370CrossRefPubMedGoogle Scholar
  8. 8.
    Deepa R, Shanthi RS, Premalatha G, Mohan V (2000) Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians—the Chennai Urban Population Study. American Diabetes Association. Diabet Med 17:872–874CrossRefPubMedGoogle Scholar
  9. 9.
    Zhou X, Pang Z, Gao W et al (2010) Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care 33:545–550.  https://doi.org/10.2337/dc09-1410 CrossRefPubMedGoogle Scholar
  10. 10.
    Li-nong J, Wei L, Wei L et al (2010) Impact of newly recommended HbA1c-based diabetes diagnostic criteria on the prevalence of diabetes and high risk individual in clinical and community population in China. Chin Med J (Engl) 123:1103–1104Google Scholar
  11. 11.
    Sun X, Du T, Huo R, Xu L (2014) Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009. Acta Diabetol 51:353–360.  https://doi.org/10.1007/s00592-013-0515-5 CrossRefPubMedGoogle Scholar
  12. 12.
    World Health Organization (2003) Screening for type 2 diabetes: report of a World Health Organization and International Diabetes Federation meeting. http://www.who.int/diabetes/publications/screening2003/en/. Accessed 1 Jan 2018
  13. 13.
    Davies MJ, Williams DR, Metcalfe J, Day JL (1993) Community screening for non-insulin-dependent diabetes mellitus: self-testing for post-prandial glycosuria. Q J Med 86:677–684CrossRefPubMedGoogle Scholar
  14. 14.
    Hanson RL, Nelson RG, McCance DR et al (1993) Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 153:2133–2140CrossRefPubMedGoogle Scholar
  15. 15.
    Friderichsen B, Maunsbach M (1997) Glycosuric tests should not be employed in population screenings for NIDDM. J Public Health Med 19:55–60CrossRefPubMedGoogle Scholar
  16. 16.
    Miyashita M, Ito N, Ikeda S et al (2009) Development of urine glucose meter based on micro-planer amperometric biosensor and its clinical application for self-monitoring of urine glucose. Biosens Bioelectron 24:1336–1340.  https://doi.org/10.1016/j.bios.2008.07.072 CrossRefPubMedGoogle Scholar
  17. 17.
    Ruhnau B, Faber OK, Borch-Johnsen K, Thorsteinsson B (1997) Renal threshold for glucose in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 36:27–33CrossRefPubMedGoogle Scholar
  18. 18.
    Rave K, Nosek L, Posner J et al (2006) Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes—results of a hyperglycaemic glucose clamp study. Nephrol Dial Transpl 21:2166–2171.  https://doi.org/10.1093/ndt/gfl175 CrossRefGoogle Scholar
  19. 19.
    Lu J, Bu RF, Sun ZL et al (2011) Comparable efficacy of self-monitoring of quantitative urine glucose with self-monitoring of blood glucose on glycaemic control in non-insulin-treated type 2 diabetes. Diabetes Res Clin Pract 93:179–186.  https://doi.org/10.1016/j.diabres.2011.04.012 CrossRefPubMedGoogle Scholar
  20. 20.
    Urakami T, Kubota S, Nitadori Y et al (2005) Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28:1876–1881CrossRefPubMedGoogle Scholar
  21. 21.
    Restrepo BI, Pino PA, Zarate I, Mora-Guzman F (2013) Dipstick urinalysis for diabetes screening in TB patients. Int Health 5:157–159.  https://doi.org/10.1093/inthealth/iht007 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Yang BQ, Lu Y, He JJ et al (2015) Performance of fasting plasma glucose and postprandial urine glucose in screening for diabetes in chinese high-risk population. Chin Med J (Engl) 128:3270–3275.  https://doi.org/10.4103/0366-6999.171353 CrossRefGoogle Scholar
  23. 23.
    Kim MS, Lee DY (2017) Urinary glucose screening for early detection of asymptomatic type 2 diabetes in Jeonbuk Province Korean Schoolchildren. J Korean Med Sci 32:985–991.  https://doi.org/10.3346/jkms.2017.32.6.985 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Malhotra RK, Indrayan A (2010) A simple nomogram for sample size for estimating sensitivity and specificity of medical tests. Indian J Ophthalmol 58:519–522.  https://doi.org/10.4103/0301-4738.71699 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Khunti K, Gillies CL, Taub NA et al (2012) A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study. Diabetes Res Clin Pract 97:505–513.  https://doi.org/10.1016/j.diabres.2012.03.009 CrossRefPubMedGoogle Scholar
  26. 26.
    Bao Y, Ma X, Li H et al (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340:c2249CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Gerich JE (2010) Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med 27:136–142.  https://doi.org/10.1111/j.1464-5491.2009.02894.x CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Qiao Q, Nakagami T, Tuomilehto J et al (2000) Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 43:1470–1475.  https://doi.org/10.1007/s001250051557 CrossRefPubMedGoogle Scholar
  29. 29.
    Jia WP, Pang C, Chen L et al (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50:286–292.  https://doi.org/10.1007/s00125-006-0503-1 CrossRefPubMedGoogle Scholar
  30. 30.
    Sun Z, He J, Qiu S et al (2015) Using serum advanced glycation end products-peptides to improve the efficacy of World Health Organization fasting plasma glucose criterion in screening for diabetes in high-risk chinese subjects. PLoS One 10:e0137756.  https://doi.org/10.1371/journal.pone.0137756 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Katulanda P, Hill NR, Stratton I et al (2016) Development and validation of a diabetes risk score for screening undiagnosed diabetes in Sri Lanka (SLDRISK). BMC Endocr Disord 16:42.  https://doi.org/10.1186/s12902-016-0124-8 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Zhang L, Zhang Z, Zhang Y, Hu G, Chen L (2014) Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999–2010. PLoS One 9:e97865.  https://doi.org/10.1371/journal.pone.0097865 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Stride A, Ellard S, Clark P et al (2005) Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28:1751–1756CrossRefPubMedGoogle Scholar
  34. 34.
    Ottosson-Laakso E, Tuomi T, Forsén B et al (2016) Influence of familial renal glycosuria due to mutations in the SLC5A2 gene on changes in glucose tolerance over time. PLoS One 11:e0146114.  https://doi.org/10.1371/journal.pone.0146114 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Nagai K, Yoshida S, Konishi H (2014) Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69:856–859PubMedGoogle Scholar
  36. 36.
    Sabolic I, Vrhovac I, Eror DB et al (2012) Expression of Na+-d-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol 302:C1174–C1188.  https://doi.org/10.1152/ajpcell.00450.2011 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Teixeira SD, Panveloski-Costa AC, Carvalho A et al (2016) Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats. Physiol Rep.  https://doi.org/10.14814/phy2.12961 PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Patel S, Fraser A, Davey SG et al (2012) Associations of gestational diabetes, existing diabetes, and glycosuria with offspring obesity and cardiometabolic outcomes. Diabetes Care 35:63–71.  https://doi.org/10.2337/dc11-1633 CrossRefPubMedGoogle Scholar
  39. 39.
    Klein P, Polidori D, Twito O, Jaffe A (2014) Impaired decline in renal threshold for glucose during pregnancy—a possible novel mechanism for gestational diabetes mellitus. Diabetes Metab Res Rev 30:140–145.  https://doi.org/10.1002/dmrr.2474 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Endocrinology, Zhongda Hospital, Institute of DiabetesSchool of Medicine, Southeast UniversityNanjingChina
  2. 2.Department of Integrated ServicesJiangsu Provincial Center for Disease Control and PreventionNanjingChina
  3. 3.Institute of Health EducationJiangsu Provincial Center for Disease Control and PreventionNanjingChina
  4. 4.Department of Endocrinology and MetabolismThe first Affiliated Hospital of Soochow UniversitySuzhouChina
  5. 5.School of Public HealthSoutheast UniversityNanjingChina

Personalised recommendations